DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Grand Cayman
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Quan Venture Fund III, L.P. | 2022 | Active deployment | $0 | $57.1M | 0 |
| Quan Venture Fund II, L.P. | 2019 | Mature | $0 | $217M | 0 |
| Quan Venture Fund I, L.P. | n/a | Unknown | $0 | $68.1M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics | n/a | Series b | $89.0M | n/a | Unknown | Mar 26, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Quan Capital | Foresite Capital | 1 | 1 | Mar 26, 2026 | One time |
| Quan Capital | HanKang Capital | 1 | 1 | Mar 26, 2026 | One time |
| Quan Capital | RA Capital Management, LP | 1 | 1 | Mar 26, 2026 | One time |
| Quan Capital | Logos Capital | 1 | 1 | Mar 26, 2026 | One time |
| Lav | Quan Capital | 1 | 1 | Mar 26, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Ying du (Sole Manager), Marietta Wu (Member And Manager), Stella X Xu (Member And Manager).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan